Works matching DE "MEDICARE Part D"
Results: 409
The Health Costs of Cost Sharing*.
- Published in:
- Quarterly Journal of Economics, 2024, v. 139, n. 4, p. 2037, doi. 10.1093/qje/qjae015
- By:
- Publication type:
- Article
What do Consumers Consider Before They Choose? Identification from Asymmetric Demand Responses.
- Published in:
- Quarterly Journal of Economics, 2021, v. 136, n. 3, p. 1611, doi. 10.1093/qje/qjab008
- By:
- Publication type:
- Article
State laws and prescribing rates of generic drugs in dermatology: a cross-sectional analysis of 2020 Medicare Part D claims data.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 10, p. 2991, doi. 10.1007/s00403-023-02719-x
- By:
- Publication type:
- Article
Trends in brand and generic drug utilization for dermatology providers from 2013–2019.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 4, p. 1041, doi. 10.1007/s00403-022-02431-2
- By:
- Publication type:
- Article
Adoption of newly FDA-approved targeted immunomodulatory therapies by dermatologists: a cross-sectional analysis of Medicare Part D claims from 2013 to 2018.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 3, p. 673, doi. 10.1007/s00403-022-02422-3
- By:
- Publication type:
- Article
The relationship between the number of available therapeutic options and government payer (medicare part D) spending on topical drug products.
- Published in:
- Archives of Dermatological Research, 2020, v. 312, n. 8, p. 559, doi. 10.1007/s00403-020-02042-9
- By:
- Publication type:
- Article
Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries - United States, 2014.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Introduction of Generic Aromatase Inhibitors and Treatment Adherence Among Medicare D Enrollees.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv130
- By:
- Publication type:
- Article
The influence of Medicare Part D on the list pricing of brand drugs.
- Published in:
- Health Services Research, 2023, v. 58, n. 4, p. 948, doi. 10.1111/1475-6773.14139
- By:
- Publication type:
- Article
Association between hospital‐physician vertical integration and medication adherence rates.
- Published in:
- Health Services Research, 2023, v. 58, n. 2, p. 356, doi. 10.1111/1475-6773.14090
- By:
- Publication type:
- Article
Five‐year impact of Medicare Part D coverage gap reform on drug expenditures and utilization.
- Published in:
- Health Services Research, 2022, v. 57, n. 1, p. 56, doi. 10.1111/1475-6773.13660
- By:
- Publication type:
- Article
Impact of the Oncology Care Model on End‐of‐Life Care.
- Published in:
- Health Services Research, 2021, v. 56, p. 18, doi. 10.1111/1475-6773.13742
- By:
- Publication type:
- Article
Impact of the Oncology Care Model on End‐of‐Life Care.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Opioid use in older adults and Medicare Part D.
- Published in:
- Health Services Research, 2021, v. 56, n. 2, p. 289, doi. 10.1111/1475-6773.13623
- By:
- Publication type:
- Article
Medicare Part D: Time for Re-Modernization?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act.
- Published in:
- Health Services Research, 2019, v. 54, n. 3, p. 636, doi. 10.1111/1475-6773.13064
- By:
- Publication type:
- Article
County-level access to opioid use disorder medications in medicare Part D (2010-2015).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Dual Use of Veterans Affairs and Medicare Part D Drug Benefits on Antihypertensive Medication Supply in a National Cohort of Veterans with Dementia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Case for Restructuring the Medicare Prescription Drug Benefit.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Trends in Opioid Use and Prescribing in Medicare, 2006-2012.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Nonlinear Pricing in Drug Benefits and Medication Use: The Case of Statin Compliance in Medicare Part D.
- Published in:
- Health Services Research, 2014, v. 49, n. 3, p. 910, doi. 10.1111/1475-6773.12145
- By:
- Publication type:
- Article
Has Medicare Part D Reduced Racial/Ethnic Disparities in Prescription Drug Use and Spending?
- Published in:
- Health Services Research, 2014, v. 49, n. 2, p. 502, doi. 10.1111/1475-6773.12099
- By:
- Publication type:
- Article
Has Medicare Part D Reduced Racial/Ethnic Disparities in Prescription Drug Use and Spending?
- Published in:
- Health Services Research, 2014, v. 49, n. 2, p. 502, doi. 10.1111/1475-6773.12099
- By:
- Publication type:
- Article
Association of Medicare Part D Medication Out-of-Pocket Costs with Utilization of Statin Medications.
- Published in:
- Health Services Research, 2013, v. 48, n. 4, p. 1311, doi. 10.1111/1475-6773.12022
- By:
- Publication type:
- Article
How Does Drug Treatment for Diabetes Compare between Medicare Advantage Prescription Drug Plans ( MAPDs) and Stand-Alone Prescription Drug Plans ( PDPs)?
- Published in:
- Health Services Research, 2013, v. 48, n. 3, p. 1057, doi. 10.1111/1475-6773.12016
- By:
- Publication type:
- Article
The Impact of Medicare Part D on Out-of-Pocket Costs for Prescription Drugs, Medication Utilization, Health Resource Utilization, and Preference-Based Health Utility.
- Published in:
- Health Services Research, 2011, v. 46, n. 4, p. 1104, doi. 10.1111/j.1475-6773.2011.01273.x
- By:
- Publication type:
- Article
The Impact of Medicare Part D on Hospitalization Rates.
- Published in:
- Health Services Research, 2011, v. 46, n. 4, p. 1022, doi. 10.1111/j.1475-6773.2011.01244.x
- By:
- Publication type:
- Article
The Impact of Medicare Part D on Medication Treatment of Hypertension.
- Published in:
- Health Services Research, 2011, v. 46, n. 1p1, p. 185, doi. 10.1111/j.1475-6773.2010.01183.x
- By:
- Publication type:
- Article
Characterizing female patients with haemophilia A: Administrative claims analysis and medical chart review.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. 520, doi. 10.1111/hae.13981
- By:
- Publication type:
- Article
Opioid and Other Medication Use and General Health Status in a Cohort of Older Adults.
- Published in:
- Gerontology, 2021, v. 67, n. 5, p. 554, doi. 10.1159/000513731
- By:
- Publication type:
- Article
Geographic trends in overall and long-acting opioid prescriptions under Medicaid and Medicare Part D in the United States, 2013–2021.
- Published in:
- American Journal of Drug & Alcohol Abuse, 2024, v. 50, n. 5, p. 690, doi. 10.1080/00952990.2024.2400916
- By:
- Publication type:
- Article
Necessity of addressing motivations for cannabis use to guide research.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Drug Pricing Stewardship from Mark Cuban's Cost Plus Generic Drug Program.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 11, p. 1279, doi. 10.1007/s40273-024-01426-3
- By:
- Publication type:
- Article
Spending, utilization, and coverage for chronic rhinosinusitis with nasal polyposis therapies among Medicare Advantage beneficiaries.
- Published in:
- International Forum of Allergy & Rhinology, 2024, v. 14, n. 10, p. 1643, doi. 10.1002/alr.23362
- By:
- Publication type:
- Article
The Inflation Reduction Act: Implications for Medicare spending and access to biologic therapies for chronic rhinosinusitis with nasal polyposis and asthma.
- Published in:
- International Forum of Allergy & Rhinology, 2024, v. 14, n. 7, p. 1261, doi. 10.1002/alr.23344
- By:
- Publication type:
- Article
Trends in price, spending, and utilization of omalizumab among Medicare beneficiaries.
- Published in:
- International Forum of Allergy & Rhinology, 2023, v. 13, n. 11, p. 2105, doi. 10.1002/alr.23185
- By:
- Publication type:
- Article
Out‐of‐pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population.
- Published in:
- International Forum of Allergy & Rhinology, 2022, v. 12, n. 10, p. 1295, doi. 10.1002/alr.22976
- By:
- Publication type:
- Article
Lock-In Programs and the Opioid Epidemic: A Call for Evidence.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
Medicare.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 314, n. 4, p. 420, doi. 10.1001/jama.2015.8049
- By:
- Publication type:
- Article
Reports: HIV Drugs Targeted for Black Market.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 11, p. 1086, doi. 10.1001/jama.2014.11153
- By:
- Publication type:
- Article
Questions for CVS Caremark.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 18, p. 2005, doi. 10.1001/jama.2010.1606
- By:
- Publication type:
- Article
Estimating New Eligibility and Maximum Costs of Expanded Medicare Coverage of Semaglutide for Cardiovascular Risk Prevention.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 10, p. 1440, doi. 10.7326/ANNALS-24-00308
- By:
- Publication type:
- Article
Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 6, p. 833, doi. 10.7326/M23-3212
- By:
- Publication type:
- Article
Cross-Sectional Analysis of Out-of-Pocket Payments for Commonly Prescribed Generic Medications Versus Discount Card Pricing.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 9, p. 1282, doi. 10.7326/M23-0644
- By:
- Publication type:
- Article
Pharmacologic Treatment Initiation Among Medicare Beneficiaries Hospitalized With Alcohol Use Disorder.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 8, p. 1137, doi. 10.7326/M23-0641
- By:
- Publication type:
- Article
Correction: Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 9, p. 1342, doi. 10.7326/L22-0294
- Publication type:
- Article
Medicare Part D Spending on Single-Enantiomer Drugs Versus Their Racemic Precursors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Local Area Variation in Morbidity Among Low-Income, Older Adults in the United States: A Cross-sectional Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Opioid Prescribing Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline.
- Published in:
- 2019
- By:
- Publication type:
- Letter